Alpine Bank Wealth Management Purchases New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Alpine Bank Wealth Management bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 345 shares of the healthcare conglomerate’s stock, valued at approximately $181,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Norges Bank bought a new position in UnitedHealth Group during the fourth quarter worth about $6,375,744,000. GAMMA Investing LLC boosted its stake in UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock valued at $4,344,586,000 after buying an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. acquired a new position in UnitedHealth Group during the fourth quarter worth $1,914,740,000. Amundi grew its holdings in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $302.19 on Thursday. The company has a fifty day simple moving average of $342.22 and a 200 day simple moving average of $458.07. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market cap of $274.13 billion, a P/E ratio of 12.65, a P/E/G ratio of 1.45 and a beta of 0.44. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the company posted $6.91 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.93%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

Analyst Ratings Changes

UNH has been the subject of a number of research analyst reports. Raymond James Financial cut shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Piper Sandler decreased their target price on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a report on Tuesday, June 3rd. UBS Group reduced their price target on shares of UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating on the stock in a research report on Wednesday. Hsbc Global Res downgraded shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Finally, KeyCorp reduced their price objective on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a report on Monday, June 2nd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $415.57.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the firm’s stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer now directly owns 10,398 shares of the company’s stock, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have bought 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.